S)-5.5,5,5',5',5'-Hexafluoroleucine ((S)-13) of 81 YO ee is prepared from hexafluoroacetone (1) and ethyl bromopyruvate (= ethyl 2-oxopropanoate) in 7 steps with an overall yield of 18% (Schemes f and 2). Key step in this sequence is the highly enantioselect~ve reduction of the carbonyl group in cc-keto ester 4 either by bakers' yeast (91 % ee) or by 'catecholborane' 6 utilizing an oxaraborolidine catalyst, yielding hydroxy ester (R)-5 with 99 %, ee. The absolute configuration was determined by X-ray analysis of the HC1 adduct (S,R)-9b of (2S)-N-[(R)-1 -phenyIethyl]-5,5,5,5',5',5'-hexafluoroleucine ethyl ester.
( -)-(R)-4,4,4,4,4,4'-Hexafluorovaline hydrochloride ((R)-5) of 98 % ee is prepared from /l,/l-bis(trifluoromcthy1)acrylic acid (= benzyl 4,4,4-trifluoro-3-(trifluoromethyl)but-2-enoate; 1) in 4 steps with ail overall yield of 9.6%. Key step is the separation of the TsOH salts of the diastereoisomers obtained by unti-Michael addition of (+)-(R)-I-phenylethylamine (2) to 1 ( + (R,R)-3). In contrast to the published (S)-chirality, the X-ray structure analysis of (R,S)-6 reveals, that (R)-chirality has to be assigned to the levorotatory (-)-4,4,4,4',4,4'-hex~fluorova-line hydrochloride.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.